Application 213544

Type
ANDA
Sponsor
AUROBINDO PHARMA LTD

Application Products#

Product, Drug, Ingredient table
ProductDrugIngredientFormStrengthReference drugReference standard
001TIZANIDINE HYDROCHLORIDETIZANIDINE HYDROCHLORIDECAPSULE;ORALEQ 2MG BASENoNo
002TIZANIDINE HYDROCHLORIDETIZANIDINE HYDROCHLORIDECAPSULE;ORALEQ 4MG BASENoNo
003TIZANIDINE HYDROCHLORIDETIZANIDINE HYDROCHLORIDECAPSULE;ORALEQ 6MG BASENoNo

NDC Listings For This Application#

NDC, Name, Nonproprietary name table
NDCNameNonproprietary nameLabelerMarketing categoryStatus
59651-314Tizanidine HydrochlorideTizanidine HydrochlorideAurobindo Pharma LimitedANDACurrent
59651-314Tizanidine HydrochlorideTizanidine HydrochlorideAurobindo Pharma LimitedANDACurrent
59651-314Tizanidine HydrochlorideTizanidine HydrochlorideAurobindo Pharma LimitedANDACurrent
59651-315Tizanidine HydrochlorideTizanidine HydrochlorideAurobindo Pharma LimitedANDACurrent
59651-315Tizanidine HydrochlorideTizanidine HydrochlorideAurobindo Pharma LimitedANDACurrent
59651-315Tizanidine HydrochlorideTizanidine HydrochlorideAurobindo Pharma LimitedANDACurrent
59651-316Tizanidine HydrochlorideTizanidine HydrochlorideAurobindo Pharma LimitedANDACurrent
59651-316Tizanidine HydrochlorideTizanidine HydrochlorideAurobindo Pharma LimitedANDACurrent
59651-316Tizanidine HydrochlorideTizanidine HydrochlorideAurobindo Pharma LimitedANDACurrent